The story of Viagra, initially marketed by copyright, presents a fascinating case study for stakeholders considering the drug sector. Although its initial success and creation of vast in revenue , the patent expiration has opened the floodgates for alternative medications, greatly diminishing profit opportunities. This change raises questions about